Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Strategic application of radiotherapy for hepatocellular carcinoma

Seo Hee Choi, Jinsil Seong

Clin Mol Hepatol. 2018;24(2):114-134. Published online February 14, 2018

DOI: https://doi.org/10.3350/cmh.2017.0073

View: 14393 Download: 389 Web of Science: 36 Crossref: 41

Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend

Grace Lai-Hung Wong

Clin Mol Hepatol. 2018;24(2):108-113. Published online January 22, 2018

DOI: https://doi.org/10.3350/cmh.2017.0068

View: 13241 Download: 513 Web of Science: 37 Crossref: 40

Epidemiology of liver cancer in South Korea

Bo Hyun Kim, Joong-Won Park

Clin Mol Hepatol. 2018;24(1):1-9. Published online December 18, 2017

DOI: https://doi.org/10.3350/cmh.2017.0112

View: 15030 Download: 489 Web of Science: 137 Crossref: 143

Case Report

Complete response of advanced hepatocellular carcinoma to sorafenib : another case and a comprehensive review

Tae Suk Kim, Ji Hoon Kim, Baek hui Kim, Young-Sun Lee, Yang Jae Yoo, Seong Hee Kang, Sang-June Suh, Young Kul Jung, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun

Clin Mol Hepatol. 2017;23(4):340-346. Published online June 20, 2017

DOI: https://doi.org/10.3350/cmh.2016.0070

View: 16260 Download: 198 Web of Science: 18 Crossref: 18

Review

Treatment options after sorafenib failure in patients with hepatocellular carcinoma

Imane El Dika, Ghassan K. Abou-Alfa

Clin Mol Hepatol. 2017;23(4):273-279. Published online November 20, 2017

DOI: https://doi.org/10.3350/cmh.2017.0108

View: 9360 Download: 233 Web of Science: 29 Crossref: 29

Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma

Edward Wolfgang Lee, Sarah Khan

Clin Mol Hepatol. 2017;23(4):265-272. Published online November 8, 2017

DOI: https://doi.org/10.3350/cmh.2017.0111

View: 11201 Download: 361 Web of Science: 37 Crossref: 36

Editorial

Surveillance of hepatocellular carcinoma: is only ultrasound enough?

Woo Kyoung Jeong

Clin Mol Hepatol. 2017;23(3):222-223. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0046

View: 6675 Download: 163 Web of Science: 7 Crossref: 6

Original Article

Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B

Won Sohn, Ju-Yeon Cho, Ji Hoon Kim, Jung Il Lee, Hyung Joon Kim, Min-Ah Woo, Sin-Ho Jung, Yong-Han Paik

Clin Mol Hepatol. 2017;23(2):170-178. Published online May 16, 2017

DOI: https://doi.org/10.3350/cmh.2016.0086

View: 9696 Download: 224 Web of Science: 52 Crossref: 45

Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion

Jihyun An, Kwang Sun Lee, Kang Mo Kim, Do Hyun Park, Sang Soo Lee, Danbi Lee, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2017;23(2):160-169. Published online May 16, 2017

DOI: https://doi.org/10.3350/cmh.2016.0088

View: 9005 Download: 240 Web of Science: 32 Crossref: 28

Meta-analysis of the correlation between the rs17401966 polymorphism in kinesin family member 1B and susceptibility to hepatitis B virus related hepatocellular carcinoma

Mingkuan Su, Jianfeng Guo, Jiancheng Huang

Clin Mol Hepatol. 2017;23(2):138-146. Published online April 21, 2017

DOI: https://doi.org/10.3350/cmh.2016.0083

View: 9171 Download: 112 Web of Science: 4 Crossref: 3

Editorial

Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?

Do Young Kim

Clin Mol Hepatol. 2017;23(2):123-124. Published online June 23, 2017

DOI: https://doi.org/10.3350/cmh.2017.0107

View: 6964 Download: 119

Review

Radioembolization for the treatment of hepatocellular carcinoma

Hyo-Cheol Kim

Clin Mol Hepatol. 2017;23(2):109-114. Published online May 10, 2017

DOI: https://doi.org/10.3350/cmh.2017.0004

View: 12541 Download: 364 Web of Science: 49 Crossref: 43

Liver Imaging

Aggressive tumor recurrence after radiofrequency ablation for hepatocellular carcinoma

Tae Wook Kang, Hyo Keun Lim, Dong Ik Cha

Clin Mol Hepatol. 2017;23(1):95-101. Published online March 24, 2017

DOI: https://doi.org/10.3350/cmh.2017.0006

View: 11417 Download: 262 Web of Science: 40 Crossref: 36

Editorial

Is scheduled second chemoembolization necessary for early stage hepatocellular carcinoma showing complete response after first chemoembolization?

Jin Wook Chung

Clin Mol Hepatol. 2017;23(1):31-33. Published online March 16, 2017

DOI: https://doi.org/10.3350/cmh.2017.0102

View: 6150 Download: 104 Web of Science: 1 Crossref: 1

Liver Imaging

Percutaneous cryoablation for hepatocellular carcinoma

Kyoung Doo Song

Clin Mol Hepatol. 2016;22(4):509-515. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0079

View: 12222 Download: 212 Web of Science: 39 Crossref: 45

Original Article

Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma

Ju-Yeon Cho, Moon Seok Choi, Gil Sun Lee, Won Sohn, Jemma Ahn, Dong-Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik

Clin Mol Hepatol. 2016;22(4):477-486. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0048

View: 9278 Download: 158 Web of Science: 24 Crossref: 21

Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization

Sun Hong Yoo, Jeong Won Jang, Jung Hyun Kwon, Seung Min Jung, Bohyun Jang, Jong Young Choi

Clin Mol Hepatol. 2016;22(4):458-465. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0054

View: 9011 Download: 134 Web of Science: 10 Crossref: 10

Comparison of hepatic MDCT, MRI, and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinoma

Lauren M. Ladd, Temel Tirkes, Mark Tann, David M. Agarwal, Matthew S. Johnson, Bilal Tahir, Kumaresan Sandrasegaran

Clin Mol Hepatol. 2016;22(4):450-457. Published online December 14, 2016

DOI: https://doi.org/10.3350/cmh.2016.0036

View: 9218 Download: 157 Web of Science: 6 Crossref: 5

Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis

Yejoo Jeon, Eun Sun Jang, Yun Suk Choi, Jin-Wook Kim, Sook-Hyang Jeong

Clin Mol Hepatol. 2016;22(3):359-365. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0033

View: 12284 Download: 146 Web of Science: 21 Crossref: 19

Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B

Jaemin Lee, Sun Hong Yoo, Won Sohn, Hyung Woo Kim, Yong Sun Choi, Jung Ho Won, Jin Young Heo, Sang Jong Park, Young Min Park

Clin Mol Hepatol. 2016;22(3):339-349. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0021

View: 11856 Download: 164 Web of Science: 19 Crossref: 19

Editorial

Does obesity increase the risk of hepatocellular carcinoma in chronic hepatitis B patients?

Byoung Kuk Jang

Clin Mol Hepatol. 2016;22(3):336-338. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0104

View: 8134 Download: 117 Web of Science: 2 Crossref: 1

Review

The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy

Ioannis Varbobitis, George V. Papatheodoridis

Clin Mol Hepatol. 2016;22(3):319-326. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0045

View: 13497 Download: 397 Web of Science: 69 Crossref: 71

Original Article

Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma

Jun Young Kim, Dong Hyun Sinn, Geum-Youn Gwak, Gyu-Seong Choi, Aldosri Meshal Saleh, Jae-Won Joh, Sung Ki Cho, Sung Wook Shin, Keumhee Chough Carriere, Joong Hyun Ahn, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik

Clin Mol Hepatol. 2016;22(2):250-258. Published online June 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0015

View: 11572 Download: 198 Web of Science: 40 Crossref: 40

Review

Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma

Massimo Roncalli, Amedeo Sciarra, Luca Di Tommaso

Clin Mol Hepatol. 2016;22(2):199-211. Published online May 18, 2016

DOI: https://doi.org/10.3350/cmh.2016.0101

View: 18701 Download: 614 Web of Science: 40 Crossref: 37

Liver Imaging

Intraductal malignant tumors in the liver mimicking cholangiocarcinoma: Imaging features for differential diagnosis

Ah Yeong Kim, Woo Kyoung Jeong

Clin Mol Hepatol. 2016;22(1):192-197. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.192

View: 11765 Download: 235 Web of Science: 11 Crossref: 13

Original Article

Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis

Jung Min Lee, Byoung Kuk Jang, Yoo Jin Lee, Wang Yong Choi, Sei Myong Choi, Woo Jin Chung, Jae Seok Hwang, Koo Jeong Kang, Young Hwan Kim, Anil Kumar Chauhan, Soo Young Park, Won Young Tak, Young Oh Kweon, Byung Seok Kim, Chang Hyeong Lee

Clin Mol Hepatol. 2016;22(1):160-167. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.160

View: 11459 Download: 197 Web of Science: 80 Crossref: 71

Review

A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016

Su Jong Yu

Clin Mol Hepatol. 2016;22(1):7-17. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.7

View: 20061 Download: 548 Web of Science: 220 Crossref: 206

Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future

Hyun Young Woo, Jeong Heo

Clin Mol Hepatol. 2015;21(4):344-348. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.344

View: 8336 Download: 195 Web of Science: 27 Crossref: 25

Original Article

Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy

Jung Gil Park

Clin Mol Hepatol. 2015;21(3):287-294. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.287

View: 8619 Download: 75 Web of Science: 26 Crossref: 28

Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease

Chansik An, Youn Ah Choi, Dongil Choi, Yong Han Paik, Sang Hoon Ahn, Myeong-Jin Kim, Seung Woon Paik, Kwang-Hyub Han, Mi-Suk Park

Clin Mol Hepatol. 2015;21(3):279-286. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.279

View: 13187 Download: 146 Web of Science: 61 Crossref: 61

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |

Viewed By 5505	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5408	MAFLD: How is it different from NAFLD?
Viewed By 5216	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5095	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4728	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 176	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 113	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 108	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 90	MAFLD: How is it different from NAFLD?
Cited By 80	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search